Molecular Modeling Database

Global Anti-Venom Market Analysis Report 2024-2032: Increasing Investments in Developing New Drugs and Technological Innovation Fueling Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 1, 2024
Health, Pharmaceutical, USD, Mortality, System, Fast Track, WHO, Fish, World Health Organization, Molecular Modeling Database, ANAVIP, Poisoning, Vaccine, Growth, Instituto Butantan, Incidence, Patient, Biting, Death, Snakebite, Therapy, Snake, NCBI, Overalls, Prevalence, Disease

The "Global Anti-Venom Market Report by Type, Animal Type, End User, Region and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Anti-Venom Market Report by Type, Animal Type, End User, Region and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.
  • The growing prevalence of snake and other animal bites, such as fish stings, drives the anti-venom market.
  • The global market for anti-venom is expected to grow due to increasing investment in developing new drugs and technological innovation in treating venomous bites.
  • The anti venom market in the U.S. is expected to have significant growth due to the country's high occurrence of snake bites.

Global Ventilators Market Focused Insights and Outlook 2024-2029 - KoninKlijke Philips, Hamilton Medical, Resmed, Medtronic & GE Healthcare Lead the Market - ResearchAndMarkets.com

Retrieved on: 
Monday, March 18, 2024
Managed Care, General Health, Oncology, Medical Devices, Infectious Diseases, Hospitals, Health Technology, Surgery, Biotechnology, Nursing, Medical Supplies, Practice Management, Health, Growth, Prevalence, Application, Molecular Modeling Database, Incidence, Patient, Ventilation, Hospital, Acute respiratory distress syndrome, GE HealthCare, Asthma, Medtronic, COPD, Nursing care plan, ICU, USD, Ageing, Medical device

The global ventilators market, valued at USD 1.75 billion in 2023, is expected to grow at a CAGR of 6.50% from 2023 to 2029.

Key Points: 
  • The global ventilators market, valued at USD 1.75 billion in 2023, is expected to grow at a CAGR of 6.50% from 2023 to 2029.
  • The global ventilators market is one of the fastest-growing segments in the medical devices market.
  • The changing healthcare services in emerging markets and significant achieved development with developed countries consistently drive the ventilator market growth.
  • KoninKlijke Philips, Hamilton Medical, Resmed, Medtronic plc, & GE Healthcare are some leading players currently dominating the global ventilators market.

Global Steerable Needles (Bevel-tip Flexible, Symmetric-tip) Market Trends Analysis Report 2023-2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 5, 2024
Medical Devices, Health, Cleveland Clinic, EPFL, NCBI, Biopsy, Government, Brushed DC electric motor, Needle, Hospital, Cancer, DSM-IV codes, USD, Molecular Modeling Database, Growth, ARC, RAS, Cardiovascular disease, Medical device

The "Steerable Needles Market Size, Share & Trends Analysis Report By Type (Bevel-tip Flexible, Symmetric-tip), By Application (Biopsy, Tumor Ablation, Robotic Assisted Surgery), By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Steerable Needles Market Size, Share & Trends Analysis Report By Type (Bevel-tip Flexible, Symmetric-tip), By Application (Biopsy, Tumor Ablation, Robotic Assisted Surgery), By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Thus, an increasing number of robotic-assisted surgery (RAS) cases are anticipated to boost demand for steerable needles during the forecast period.
  • These advancements have led to the development of more precise and accurate steerable needles and steerable needles that are compatible with a wide range of imaging modalities.
  • This initiative will strengthen the adoption of newly launched steerable needles worldwide, thereby driving the market growth.

Filter Needles Market Size, Share & Trends Report 2023-2030: Global Analysis by Raw Material (Stainless Steel, Glass), and End-use (Hospital, Clinics, Ambulatory Surgery Centers) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 29, 2023
Medical Devices, Health, Foot, Stainless steel, Mouth ulcer, Ankle, Ambulatory Surgery Center Association, Prevalence, Ulcer, Glass, Incidence, Needle, Disability, Patient, USD, Molecular Modeling Database, NCBI, Ageing, Vein, Recurrence, Diabetes, Hospital, Pharmaceutical industry

The "Filter Needles Market Size, Share & Trends Analysis Report By Raw Material (Stainless Steel, Glass, Others), By End-use (Hospital, Clinics, Ambulatory Surgery Centers, Others), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Filter Needles Market Size, Share & Trends Analysis Report By Raw Material (Stainless Steel, Glass, Others), By End-use (Hospital, Clinics, Ambulatory Surgery Centers, Others), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global filter needles market size is expected to reach USD 2.9 billion by 2030.
  • The increasing geriatric population, technological advancements, and rising prevalence of chronic wounds are the key factors driving the market.
  • The increasing prevalence of various chronic wounds across the globe is anticipated to drive the market over the forecast period.

Malaysia Healthcare Promotes Regular Screenings for Breast Cancer Prevention

Retrieved on: 
Tuesday, October 31, 2023
Nipple discharge, 3D, Breast self-examination, Survival, Research, National Center for Functional Glycomics, MRI, Ageing, Breast, Molecular Modeling Database, Flaky pastry, UMSC, Breast pain, BRCA1, Mortality, Skin, Economist, Breast-conserving surgery, BRCA2, Economist Intelligence Unit, Recurrence, Breast cancer, Survival rate, Stage 4, Blood, Swelling, Red, National Center for Biotechnology Information, Bandar Sunway, Agent handling, Woman, Cancer, Pain, Patient, Diagnosis, Associate, Medical imaging, Hospital

KUALA LUMPUR, Malaysia, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Malaysia Healthcare encourages global citizens to practice regular examination and screenings as a crucial step in preventing breast cancer.

Key Points: 
  • KUALA LUMPUR, Malaysia, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Malaysia Healthcare encourages global citizens to practice regular examination and screenings as a crucial step in preventing breast cancer.
  • With healthcare facilities that are equipped with innovative screening procedures, Malaysia Healthcare is committed to making breast cancer early detection accessible for global citizens.
  • In conjunction with the breast cancer awareness month, Malaysia Healthcare shed light on the significance of early diagnosis as well as the cutting-edge screening procedures provided by several of its healthcare facilities.
  • “We strongly advocate regular self-examination and frequent breast screening especially for women aged 40 and above to detect breast cancer at an early stage.

LiveCare Announces Middle East Expansion Initiative

Retrieved on: 
Tuesday, October 24, 2023
National Centers for Environmental Information, Kuwait, Molecular Modeling Database, Type, United Arab Emirates, OTC Markets Group, Prevalence, Urbanization, Diabetes, Business, National Center for Biotechnology Information, Economic development, Travel, Traction, Pharmaceutical industry, Kingdom

Venice, FL, USA, Oct. 24, 2023 (GLOBE NEWSWIRE) -- LiveCare, Inc. OTC:LVCE, a leader in the telehealth sector assisting people living with type II diabetes—often overlooked—become healthier and remain connected, has officially announced its Middle East Expansion Initiative.

Key Points: 
  • Venice, FL, USA, Oct. 24, 2023 (GLOBE NEWSWIRE) -- LiveCare, Inc. OTC:LVCE, a leader in the telehealth sector assisting people living with type II diabetes—often overlooked—become healthier and remain connected, has officially announced its Middle East Expansion Initiative.
  • The Middle East Expansion Initiative of LiveCare Inc. commenced with a journey to the United Arab Emirates in September, undertaken by Jack Brannelly, Feras Al Kandari, and Max Rockwell.
  • The team had several high profile meetings with local officials and business owners who are very interested in working with LiveCare.
  • LiveCare is in the process of solidifying its local footprint by forming a business entity registered with Dubai Health Care City ( www.dhcc.ae ).

COVID-19 Pandemic Spurs Demand: Urinary Drainage Bags Vital for Efficient Patient Care in Hospitals - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 20, 2023
Hospitals, Health, Medical Supplies, National Center for Health Statistics, Urinary incontinence, UI, Prevalence, Reusability, Neurogenic bladder dysfunction, COVID-19, NCBI, Ageing, National Center for Biotechnology Information, USD, Compound annual growth rate, Patient, Risk, Urinary retention, Kidney, Growth, Urinary tract infection, Molecular Modeling Database, Pharmaceutical industry

Key drivers propelling this growth include the increasing aging population, favorable reimbursement policies, and a rising prevalence of urological diseases.

Key Points: 
  • Key drivers propelling this growth include the increasing aging population, favorable reimbursement policies, and a rising prevalence of urological diseases.
  • The continuous uptick in urological disorders such as urinary retention, cystitis, benign prostatic hyperplasia, Urinary Incontinence (UI), and kidney stones, all contributing to bladder dysfunction, underscores the growing demand for urinary drainage bags.
  • This underscores the increasing need for urinary drainage bags and fuels market growth over the forecast period.
  • This heightened demand for efficient patient care in hospital settings is projected to drive significant and sustained market growth post-pandemic.

Slimming Sprinkles Launches Menopause Health, Wellness & Lifestyle Website

Retrieved on: 
Thursday, July 27, 2023
National Center for Women & Information Technology, Mayo Clinic, Prevalence, Education, Garlic, Ageing, Woman, National Center for Biotechnology Information, Research, Bangladesh Technical Education Board, Hormone, Ginger, Happiness, Motivation, Menopause, Clinical professor, Health, Wellness, Molecular Modeling Database, Birth control

Slimming Sprinkles is a new website offering perimenopausal, menopausal, and postmenopausal women scientifically backed health, wellness, and lifestyle advice.

Key Points: 
  • Slimming Sprinkles has been designed to offer menopausal women-who the site's founder Chris Munch believes are often neglected in primary healthcare settings-accurate and well-researched information.
  • Slimming Sprinkles Launches Menopause Health, Wellness & Lifestyle Website
    To view an enhanced version of this graphic, please visit:
    The new site focuses on delivering information that can help women understand the transformations that are taking place in their body, and develop strategies to maintain a sense of wellness, happiness and vitality as these changes take place.
  • As the new Slimming Sprinkles website explains, menopause is a phase of life that spans many years, with most women experiencing the first symptoms of menopause-on average-six to ten years before their final menstrual period.
  • It's important to educate women about healthy menopause management since menopause is a very transformative period in a woman's life."

High School Student Researchers Find New Brain Tumor Drug Targets Using AI

Retrieved on: 
Tuesday, May 2, 2023
Spanish National Center for Biotechnology, Pine Crest School, Neuron, Drug development, GBM, Drug discovery, Sevenoaks School, Survival, Ageing, Cancer, National Center for Biotechnology Information, Brain, Research, Gene expression, Biomarker, Cell, Aging Research and Drug Discovery, Doctor of Philosophy, Glioblastoma, Science, Student, GLUD1, Shanghai High School International Division, Patient, Dark Ages, Gene Expression Omnibus, Insilico Medicine, Neuroscience, Biology, Growth, AI, Longevity, Gene, Medicine, CNGA3, Molecular Modeling Database, Mobile phone, Pharmaceutical industry, Medical device, In silico

GBM is the most aggressive and common malignant brain tumor, accounting for 16% of all primary brain tumors.

Key Points: 
  • GBM is the most aggressive and common malignant brain tumor, accounting for 16% of all primary brain tumors.
  • Olsen, a student at Sevenoaks School in Kent, UK, began interning at Insilico Medicine in 2021, after discovering her interest in neurobiology and technology.
  • Ren, a student at Shanghai High School International Division, has an interest in biology and biomarkers and joined them in the summer of 2022.
  • He discovered generative AI drug discovery company Insilico Medicine whose founder and CEO, Alex Zhavoronkov, PhD, connected him with Olsen.

Student Researchers Use UAE-Developed Generative AI Technology to Find New Brain Tumor Drug Targets

Retrieved on: 
Tuesday, May 2, 2023
Spanish National Center for Biotechnology, Pine Crest School, Neuron, Drug development, GBM, Drug discovery, Sevenoaks School, Survival, Ageing, Cancer, National Center for Biotechnology Information, Brain, Research, Gene expression, Biomarker, Cell, Aging Research and Drug Discovery, Doctor of Philosophy, Glioblastoma, Science, Student, GLUD1, Shanghai High School International Division, Patient, Dark Ages, Gene Expression Omnibus, Insilico Medicine, Neuroscience, Artificial intelligence, Biology, Growth, AI, Longevity, Gene, State Farm Research and Development Center, Medicine, CNGA3, Molecular Modeling Database, Mobile phone, Medical device, Pharmaceutical industry, In silico

GBM is the most aggressive and common malignant brain tumor, accounting for 16% of all primary brain tumors.

Key Points: 
  • GBM is the most aggressive and common malignant brain tumor, accounting for 16% of all primary brain tumors.
  • Olsen, a student at Sevenoaks School in Kent, UK, began interning at Insilico Medicine in 2021, after discovering her interest in neurobiology and technology.
  • He discovered generative AI drug discovery company Insilico Medicine whose founder and CEO, Alex Zhavoronkov, PhD, connected him with Olsen.
  • It really kick-started my entire career.”
    “I am truly impressed by the commitment of these young researchers,” says Zhavoronkov.